Sponsored by:
Is Pharma Ready To Embrace Virtual Trials
Using a virtual, or decentralized, approach to clinical trials has the potential to improve patient experience and data quality while also accelerating the time it takes to get new drugs on the market. Although these benefits have been apparent for years, the COVID-19 pandemic created an urgent need to implement virtual approaches.
This quick transition demonstrated that these patient-centric models can work even on large scales. It also helped those involved in clinical trials feel more comfortable and confident in virtual approaches that will likely be the new normal moving forward.
As clinical trials incorporate more virtual components, study teams and sites need more patient information, clinical insight, and control with less system complexity and burden. Oracle Health Sciences developed the Clinical One advanced eClinical platform to support all types of trials in the simplest, most user-friendly way, providing a way to collect and manage all the clinical data in one place.
About Oracle Health Sciences
As a leader in Life Sciences cloud technology, Oracle Health Sciences’ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years’ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes. Oracle Health Sciences. For life.
